Literature DB >> 6283175

Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant.

B A Larder, G Darby.   

Abstract

The acyclovir-resistant mutant of herpes simplex virus type 1, SC16 S1, induced reduced levels of thymidine kinase activity (ca. 25% reduction) in infected cells. The activity appeared with kinetics similar to that in wild type-infected cells, and pulse-labeling experiments showed that the thymidine kinase polypeptide was synthesized at a similar rate. We showed that the enzyme was virus specific by inactivating it with antiserum raised against herpes simplex virus-infected cell proteins. The enzyme induced by the mutant had reduced electrophoretic mobility in nondenaturing gels, decreased thermal stability, and decreased affinity for several different substrates (assessed by measurement of Km values) compared with the enzyme induced by the wild type. From the data obtained we conclude that the thymidine kinase induced by the mutant has an altered specificity, probably resulting from an amino acid substitution which affects the primary binding site for nucleosides and nucleoside analogs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283175      PMCID: PMC256890     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Properties of mitochondrial thymidine kinases of parental and enzyme-deficient HeLa cells.

Authors:  S Kit; W C Leung; D Trkula
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

2.  A new rapid assay for measuring deoxycytidylate- and deoxythymidylate-kinase activities.

Authors:  Y C Cheng; W H Prusoff
Journal:  Anal Biochem       Date:  1974-08       Impact factor: 3.365

3.  Differences in the properties of thymidine kinase produced in cells infected with type 1 and type 2 herpes virus.

Authors:  M E Thouless; G R Skinner
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

4.  Differences in thermal stability of deoxythymidine kinase activity in extracts from cell infected with herpes simplex virus type 1 or type 2.

Authors:  T Ogino; F Rapp
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

6.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

7.  The immunological specificity of thymidine kinases in cells infected by viruses of the herpes group.

Authors:  A Buchan; D H Watson
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

8.  Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors:  D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

9.  A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus.

Authors:  H G Klemperer; G R Haynes; W I Shedden; D H Watson
Journal:  Virology       Date:  1967-01       Impact factor: 3.616

10.  A proton exchange between purines and water and its application to biochemistry.

Authors:  K R Shelton; J M Clark
Journal:  Biochemistry       Date:  1967-09       Impact factor: 3.162

View more
  9 in total

1.  Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Authors:  M N Ellis; P M Keller; J A Fyfe; J L Martin; J F Rooney; S E Straus; S N Lehrman; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

2.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

3.  In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

Authors:  E L Hill; G A Hunter; M N Ellis
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.

Authors:  J L Martin; M N Ellis; P M Keller; K K Biron; S N Lehrman; D W Barry; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.

Authors:  S Shigeta; S Mori; T Yokota; K Konno; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

6.  Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1.

Authors:  M N Ellis; R Waters; E L Hill; D C Lobe; D W Selleseth; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  Cooperative effects between two acyclovir resistance loci in herpes simplex virus.

Authors:  G Darby; M J Churcher; B A Larder
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

Review 8.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

9.  Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.

Authors:  V Veerisetty; G A Gentry
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.